Paradigm Biocapital Advisors’s Cullinan Oncology CGEM Stock Holding History

Quarter	Market Value	Status	Shares	Shares Change %	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-2,321,013	Closed	-$38.9M	–	31
2024 Q3	$38.9M	Buy	2,321,013 +778,208	+50%	+$13M	1.31%	24
2024 Q2	$26.9M	Buy	1,542,805 +194,790	+14%	+$3.4M	1.03%	26
2024 Q1	$23M	Buy	+1,348,015	New	+$23M	0.81%	26